Axsome Therapeutics Inc. (AXSM)
NASDAQ: AXSM
· Real-Time Price · USD
124.33
-0.08 (-0.06%)
At close: Sep 05, 2025, 1:10 PM
Axsome Therapeutics Revenue
Axsome Therapeutics reported an annual revenue of $385.69M, reflecting a 42.53% growth. For the quarter ending June 30, 2025, Axsome Therapeutics generated $150.04M in revenue.
Revenue (ttm)
385.69M
Revenue Growth
42.53%
Price / Sales Ratio
10.51
Revenue / Employee
541.7K
Employees
712
Market Cap
6.2B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 385.69M | +42.53% |
| Dec 31, 2023 | 270.6M | +440.80% |
| Dec 31, 2022 | 50.04M | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |